SSTR2 and neoplasm: Although Laverman et al. obtained promising preclinical results with [18F]AlF-NOTA-octreotide in SSTR2 positive tumor mice, additional preclinical results with [18F]AlF-NOTA-octreotide are warranted to proceed with the clinical evaluation of [18F]AlF-NOTA-octreotide.